AFP and trisomy 21: For trisomy 21, the results revealed that the substitution of AFP-L2 for AFP improved the IDI and NRI by 9.56% and 26.50%, respectively, that AFP-L3 substitution for AFP augmented the IDI and NRI by 12.34% and 26.70%, respectively.